参考文献:1. Bhagirath KM, Paulson K, Ahmadie R, Bhalla RS, Robinson D, Jassal DS. Clinical utility of cardiac magnetic resonance imaging in Churg–Strauss syndrome: case report and review of the literature. Rheumatol Int 2009;29:445-. f="http://dx.doi.org/10.1007/s00296-008-0700-y">CrossRef 2. Blanchard C, Rothenberg ME. Biology of the eosinophil. Adv Immunol 2009;101:81-21. f="http://dx.doi.org/10.1016/S0065-2776(08)01003-1">CrossRef 3. Cartin-Ceba R, Keogh KA, Specks U, Sethi S, Fervenza FC. Rituximab for the treatment of Churg–Strauss syndrome with renal involvement. Nephrol Dial Transplant 2011; 26:2865-1. f="http://dx.doi.org/10.1093/ndt/gfq852">CrossRef 4. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951;27:277-01. 5. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-4. f="http://dx.doi.org/10.1056/NEJMoa025217">CrossRef 6. Donvik KK, Omdal R. Churg–Strauss syndrome successfully treated with rituximab. Rheumatol Int 2009;31:89-1. f="http://dx.doi.org/10.1007/s00296-009-1146-6">CrossRef 7. Gotlib J. Eosinophilic myeloid disorders: new classification and novel therapeutic strategies. Curr Opin Hematol 2010;17:117-4. f="http://dx.doi.org/10.1097/MOH.0b013e3283366c70">CrossRef 8. Greenan TJ, Grossman RI, Goldberg HI. Cerebral vasculitis: MR imaging and angiographic correlation. Radiology 1992;182:65-2. 9. Guillevin L, Cohen P, Mahr A, et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 2003;49:93-00. f="http://dx.doi.org/10.1002/art.10922">CrossRef 10. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg–Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996;75:17-8. f="http://dx.doi.org/10.1097/00005792-199601000-00003">CrossRef 11. Heiserman JE, Drayer BP, Keller PJ, Fram EK. Intracranial vascular stenosis and occlusion: evaluation with three-dimensional time-of-flight MR 12. angiography. Radiology 1992;185:667-3. 12. Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008;38:709-0. f="http://dx.doi.org/10.1111/j.1365-2222.2008.02958.x">CrossRef 13. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-2. f="http://dx.doi.org/10.1002/art.1780370206">CrossRef 14. Kahn JE, Grandpeix-Guyodo C, Marroun I, et al. Sustained response to mepolizumab in refractory Churg–Strauss syndrome. J Allergy Clin Immunol 2010;125:267-0. f="http://dx.doi.org/10.1016/j.jaci.2009.10.014">CrossRef 15. Kim S, Marigowda G, Oren E, Israel E, Wechsler ME. Mepolizumab as a steroid-sparing treatment option in patients with Churg–Strauss syndrome. J Allergy Clin Immunol 2010;125:1336-3. f="http://dx.doi.org/10.1016/j.jaci.2010.03.028">CrossRef 16. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg–Strauss syndrome. Medicine (Baltimore) 1984;63:65-1. 17. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-00. f="http://dx.doi.org/10.1002/art.1780330806">CrossRef 18. Metzgeroth G, Walz C, Erben P, et al. Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study. Br J Haematol 2008;143:707-5. f="http://dx.doi.org/10.1111/j.1365-2141.2008.07294.x">CrossRef 19. Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-3. f="http://dx.doi.org/10.1056/NEJMoa0805435">CrossRef 20. Pagnoux C, Guilpain P, Guillevin L. Churg–Strauss syndrome. Curr Opin Rheumatol 2007;19:25-2. f="http://dx.doi.org/10.1097/BOR.0b013e3280119854">CrossRef 21. Ribi C, Cohen P, Pagnoux C, et al. Treatment of Churg–Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum 2008;58:586-4. f="http://dx.doi.org/10.1002/art.23198">CrossRef 22. Rothenberg ME, Klion AD, Roufosse FE, et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008;358:1215-8. f="http://dx.doi.org/10.1056/NEJMoa070812">CrossRef 23. Sable-Fourtassou R, Cohen P, Mahr A, et al. Antineutrophil cytoplasmic antibodies and the Churg–Strauss syndrome. Ann Intern Med 2005;143:632-. 24. Saech J, Owczarczyk K, Rosgen S, Petereit H, Hallek M, Rubbert-Roth A. Successful use of rituximab in a patient with Churg–Strauss syndrome and refractory central nervous system involvement. Ann Rheum Dis 2010;69:1254-. f="http://dx.doi.org/10.1136/ard.2009.109850">CrossRef 25. Sehgal M, Swanson JW, DeRemee RA, Colby TV. Neurologic manifestations of Churg–Strauss syndrome. Mayo Clin Proc 1995;70:337-1. f="http://dx.doi.org/10.4065/70.4.337">CrossRef 26. Sinico RA, Di Toma L, Maggiore U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg–Strauss syndrome. Arthritis Rheum 2005;52:2926-5. f="http://dx.doi.org/10.1002/art.21250">CrossRef 27. Stock KW, Radue EW, Jacob AL, Bao XS, Steinbrich W. Intracranial arteries: prospective blinded comparative study of MR angiography and DSA in 50 patients. Radiology 1995;195:451-. 28. Wadleigh M, Tefferi A. Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria. Int J Hematol 2010;91:174-. f="http://dx.doi.org/10.1007/s12185-010-0529-5">CrossRef 29. Zwerina J, Axmann R, Jatzwauk M, Sahinbegovic E, Polzer K, Schett G. Pathogenesis of Churg–Strauss syndrome: recent insights. Autoimmunity 2009;42:376-. f="http://dx.doi.org/10.1080/08916930902832348">CrossRef
作者单位:Alana B. Levine MD (1) George Kalliolias PhD (1) Mark Heaney MD, PhD (2) Yoshimi Endo MD (3) Adam Gersten MD (4) Jonathan W. Weinsaft MD (5) Robert F. Spiera MD (1) Anne Bass MD (1) Doruk Erkan MD (1)
1. Division of Rheumatology, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA 2. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA 3. Department of Radiology, Hospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA 4. Department of Pathology, Weill-Cornell Medical College–New York Presbyterian Hospital, New York, NY, 10065, USA 5. Division of Cardiology, Weill-Cornell Medical College–New York Presbyterian Hospital, New York, NY, 10065, USA